Diabetes

Study identifies target for diabetes drug

New research from the University of Cincinnati (UC) points to the naturally produced protein apolipoprotein A-IV (apoA-IV) as a potential target for a new diabetes therapeutic.

Diseases, Conditions, Syndromes

A unique enzyme could be a game-changer for gluten-sensitive patients

Researchers have found that taking an enzyme tablet while consuming foods containing gluten prevents a significant amount of it from entering the small intestine. This could enable gluten-sensitive patients to ingest small ...

Pediatrics

A regimen for treating environmental enteric dysfunction

A team of medical researchers at Washington University School of Medicine, working with colleagues from the University of Zambia School of Medicine and Cedars-Sinai Medical Center, has developed a regimen for treating children ...

Cardiology

Gut protein mutations shield against spikes in glucose

Why is it that, despite consuming the same number of calories, sodium and sugar, some people face little risk of diabetes or obesity while others are at higher risk? A new study by investigators at Brigham and Women's Hospital ...

page 19 from 33